Publicacions
-
Puerto-Camacho P, Amaral AT, Lamhamedi-Cherradi SE, Menegaz BA, Castillo H, Ordóñez JL, Dominguez-Hormaetxe S, Jordan-Perez C, Diaz-Martin J, Romero-Pérez L, Lopez-Alvarez M, Civantos-Jubera G, Robles-Frias MJ, Biscuola M, Ferrer C, Mora J, Cuglievan B, Schadler KL, Seifert O, Kontermann RE, Pfizenmaier K, Simon L, Fabre M, Carcaboso AM, Ludwig JA and de Álava E.
Preclinical Efficacy of Endoglin-Targeting Antibody-Drug Conjugates for the Treatment of Ewing Sarcoma
CLINICAL CANCER RESEARCH . 25(7): 2228-2240. Nº de cites: 30
-
Przystal JM, Waramit S, Pranjol MZI, Yan W, Chu G, Chongchai A, Samarth G, Gene-Olaciregui N, Tabatabai G, Carcaboso AM, Aboagye EO, Suwan K and Hajitou A.
Efficacy of systemic temozolomide-activated phage-targeted gene therapy in human glioblastoma
EMBO Molecular Medicine . 11(4): . Nº de cites: 59
-
Asnaghi L, White DT, Key N, Choi J, Mahale A, Alkatan H, Edward DP, Elkhamary SM, Al-Mesfer S, Maktabi A, Hurtado CG, Lee GY, Carcaboso AM, Mumm JS, Safieh LA and Eberhart CG.
ACVR1C/SMAD2 signaling promotes invasion and growth in retinoblastoma
Oncogene . 38(12): 2056-2075. Nº de cites: 34
-
Winter U, Aschero R, Fuentes F, Buontempo F, Zugbi S, Sgroi M, Sampor C, Abramson DH, Carcaboso AM and Schaiquevich P.
Tridimensional Retinoblastoma Cultures as Vitreous Seeds Models for Live-Cell Imaging of Chemotherapy Penetration
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES . 20(5): . Nº de cites: 17
-
Puerta-Roldan P, López VS, Morales-La Madrid A, Cruz-Martínez O, Muchart-Lopez J, Thomas C and Guillen-Quesada A.
Vanishing diffuse leptomeningeal contrast enhancement in an infant with choroid plexus papilloma.
ACTA NEUROCHIRURGICA . 161(2): 351-354. Nº de cites: 4
-
Abu Arja MH, Stanek JR, Morales-La Madrid A, Lassaletta A, Bartels U, Qaddoumi I, Finlay JL and Osorio DS.
The Latin American Brain Tumor Board teleconference: results of a web-based survey to evaluate participant experience utilizing this resource.
CHILDS NERVOUS SYSTEM . 35(2): 257-265. Nº de cites: 13
-
Pascual-Pastó G, Bazan-Peregrino M, Gene-Olaciregui N, Restrepo-Perdomo CA, Mato-Berciano A, Ottaviani D, Weber K, Correa MG, Paco-Mercader S, Vilà-Ubach M, Cuadrado-Vilanova M, Castillo H, Botteri G, García-Gerique L, Moreno-Gilabert H, Gimenez-Alejandre M, Alonso-Lopez P, Farrera-Sal M, Torres-Manjon S, Ramos-Lozano D, Moreno R, Aerts I, Doz F, Cassoux N, Chapeaublanc E, Torrebadell-Burriel M, Roldan-Molina M, König A, Suñol M, Claverol J, Lavarino C, de Torres C, Fu L, Radvanyi F, Munier FL, Català-Mora J, Mora J, Alemany R, Cascallo M, Chantada G and Carcaboso AM.
Therapeutic targeting of the RB1 pathway in retinoblastoma with the oncolytic adenovirus VCN-01
SCIENCE TRANSLATIONAL MEDICINE . 11(476): 9321. Nº de cites: 77
-
Lobon-Iglesias MJ, Salvador-Marcos N, Puerta Roldan P, Candela-Cantó SA, Ramos-Albiac M, Gómez-Chiari M, Puget S, Bolle S, Goumnerova L, Kieran MW, Cruz-Martínez O, Grill J and Morales-La Madrid A.
Tumor dissemination through surgical tracts in diffuse intrinsic pontine glioma.
JOURNAL OF NEUROSURGERY-PEDIATRICS . 22(6): 678-683. Nº de cites: 8
-
Meel MH, de Gooijer MC, Guillén Navarro M, Waranecki P, Breur M, Buil L, Wedekind LE, Twisk JWR, Koster J, Hashizume R, Raabe EH, Carcaboso AM, Bugiani M, van Tellingen O, van Vuurden DG, Kaspers GJL and Hulleman E.
MELK Inhibition in Diffuse Intrinsic Pontine Glioma
CLINICAL CANCER RESEARCH . 24(22): 5645-5657. Nº de cites: 34
-
Torbidoni AV, Sampor C, Laurent VE, Aschero MR, Iyer S, Rossi J, Alderete D, Alonso DF, Szijan I and Chantada G.
Minimal disseminated disease evaluation and outcome in trilateral retinoblastoma
BRITISH JOURNAL OF OPHTHALMOLOGY . 102(11): 1597-1601. Nº de cites: 5